Soru

Zorluk: ZorGastroenterology and Hepatology

A 5858-year-old woman comes to the outpatient clinic reporting a 55-month history of frequent, foul-smelling, bulky stools accompanied by severe abdominal bloating and progressive fatigue. Her medical history is significant for diffuse cutaneous systemic sclerosis. Vital signs are normal. Physical examination shows thickened, tight skin over the face and fingers, as well as decreased vibratory sensation in the distal lower extremities bilaterally. Abdominal examination reveals mild distension with tympany but no tenderness or guarding. Laboratory evaluation shows a hemoglobin concentration of 9.1 g/dL9.1 \text{ g/dL} and a mean corpuscular volume of 115 fL115 \text{ fL}. Serum vitamin B12B_{12} levels are markedly reduced, while serum folate concentration is significantly elevated above the reference range. Which of the following is the most appropriate next step in the diagnostic or therapeutic management of this patient?

  1. Measurement of exhaled hydrogen and methane following an oral glucose loadCevap
  2. B
    Serologic testing for anti-intrinsic factor and anti-parietal cell antibodies
  3. C
    Hospital admission for intravenous broad-spectrum antibiotic therapy
  4. D
    Plain radiography of the abdomen and immediate surgical consultation
  5. E
    Discontinuation of current immunosuppressive therapy and initiation of a root cause analysis

Cevap

Measurement of exhaled hydrogen and methane following an oral glucose load
The correct answer is measurement of exhaled hydrogen and methane following an oral glucose load. This patient's clinical presentation is highly characteristic of Small Intestinal Bacterial Overgrowth (SIBO). Systemic sclerosis causes smooth muscle fibrosis and severe intestinal dysmotility, creating a state of stasis that allows colonic bacteria to proliferate in the small intestine. This bacterial overgrowth leads to malabsorption and steatorrhea (foul-smelling stools, bloating). The classic laboratory hallmark of SIBO is a macrocytic anemia featuring low vitamin B12B_{12} and elevated folate levels. This divergence occurs because the overgrown enteric bacteria actively consume dietary vitamin B12B_{12} (causing deficiency and subsequent neurological symptoms like decreased vibratory sensation) while simultaneously synthesizing large amounts of folate, which is then absorbed by the host. A carbohydrate (glucose or lactulose) breath test is the preferred non-invasive method to confirm the diagnosis by detecting early peaks in exhaled hydrogen or methane gases.

Adım Adım Çözüm

1
Analyze the patient's underlying disease process and gastrointestinal symptoms.
The patient has systemic sclerosis (scleroderma), which causes smooth muscle atrophy and fibrosis in the gastrointestinal tract, leading to profound intestinal dysmotility and subsequent stasis.
Establishing the pathophysiological baseline explains her risk for subsequent complications.
2
Interpret the specific pattern of laboratory abnormalities.
There is a macrocytic anemia (115 fL115 \text{ fL}) with low vitamin B12B_{12} but elevated folate.
This specific divergence (low B12B_{12}, high folate) is the hallmark metabolic signature of Small Intestinal Bacterial Overgrowth (SIBO). Enteric bacteria consume dietary vitamin B12B_{12} but synthesize folate.
3
Determine the diagnostic test of choice for the suspected condition.
A carbohydrate breath test (glucose or lactulose) is indicated.
Breath testing measures hydrogen and methane gases produced by bacterial fermentation in the small intestine, confirming the diagnosis of SIBO before initiating targeted oral antibiotic therapy (e.g., rifaximin).

Anahtar Kavram

Small Intestinal Bacterial Overgrowth (SIBO) Diagnosis and Pathophysiology
Bu soruyu puanla